Meiragtx
Develops genetic medicines and gene-regulation technologies for patients with rare and common diseases
Highlights
- Hiring8 open roles
- New on EvolcAdded 2026-10-29
About Meiragtx
MeiraGTx develops genetic medicines for inherited and more common diseases, with programs spanning eye disorders, radiation-induced xerostomia and Parkinson’s disease. Its technologies include viral-vector optimization, in-house GMP manufacturing and a riboswitch platform for controlling gene expression with oral small molecules.
The company is clinical-stage and has a pipeline that includes late-stage clinical programs. Its open roles span research and development, manufacturing, quality control, engineering and statistical programming, with positions in London, Shannon, New York City and remotely.
Product: Genetic medicines, viral-vector technologies, riboswitch gene regulation and GMP manufacturing capabilities.
Jobs at Meiragtx (8)
Meiragtx is hiring for 8 roles, mostly in manufacturing, based in London and Shannon. One is remote.
Senior Quality Manager - Systems & Compliance
New on EvolcBioprocessing Team Leader
New on EvolcBioprocessing Scientist
New on EvolcResearch Associate
New on EvolcQC Validation Specialist
New on EvolcQC Stability Manager
New on EvolcQC Specialist
New on Evolc
Companies hiring like Meiragtx
Leadership
- Michel Michaelides · Head of Clinical OphthalmologySource: company website
- Alexandria Forbes · President and Chief Executive OfficerSource: company website
- Richard Giroux · Chief Operating Officer and Chief Financial OfficerSource: company website
More biotech & pharma companies
Mestag Therapeutics
Immunology company developing first-in-class antibodies for cancer and inflammatory diseases based on fibroblast biologyNew on EvolcMetrion Biosciences
Preclinical CRO running ion channel, cardiac safety and neuroscience screening for pharma and biotech drug discoveryNew on EvolcMialgae
Fish-free algae DHA omega-3 ingredient for pet food and aquafeed makers, grown on Scottish whisky by-productsNew on EvolcMicregen
Cell-free stem cell secretome therapies in preclinical development, starting with a treatment for premature-infant NECNew on EvolcMicrobiotica
Clinical-stage biopharma developing microbiome-based live biotherapeutics for melanoma and ulcerative colitis patientsNew on EvolcMicropharm
Develops and manufactures polyclonal antibody medicines, including antivenoms, for healthcare marketsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Bootstrap
- Google Tag Manager
- OneTrust
- Personio
- WordPress
- jQuery
- nginx
